Antioxidative/oxidative effects and retarding osteoconductivity of ciprofloxacin-loaded porous polyvinyl alcohol/bioactive glass hybrid
暂无分享,去创建一个
Salha Boulila | Hassane Oudadesse | Riadh Badraoui | Bertrand Lefeuvre | Mostafa Mabrouk | Khansa Chaabouni | Amany Mostafa | Fatma Makni-Ayedi | Allal Barroug | Tarek Rebai | Abdelfattah Elfeki | Hafed Elfeki | M. Mabrouk | T. Rebai | R. Badraoui | H. Oudadesse | H. Elfeki | S. Boulila | K. Chaabouni | A. Mostafa | B. Lefeuvre | A. Elfeki | A. Barroug | Fatma Makni-Ayedi
[1] M. S. Raj,et al. Nanocomposites Based on Polymer and Hydroxyapatite for Drug Delivery Application , 2013 .
[2] M E Bolander,et al. Ciprofloxacin Inhibition of Experimental Fracture-Healing* , 2000, The Journal of bone and joint surgery. American volume.
[3] A. Fassihi,et al. Implantable Controlled Release Drug Delivery Systems: A Review , 1991 .
[4] M. Rahaman. Bioactive ceramics and glasses for tissue engineering , 2014 .
[5] María Vallet-Regí,et al. Nanostructured mesoporous silicas for bone tissue regeneration , 2008 .
[6] I. Albesa,et al. Comparison of oxidative stress induced by ciprofloxacin and pyoverdin in bacteria and in leukocytes to evaluate toxicity. , 2003, Luminescence : the journal of biological and chemical luminescence.
[7] O. Afolabi,et al. Effects of Ciprofloxacin and Levofloxacin Administration on Some Oxidative Stress Markers in the Rat , 2014 .
[8] G. Schmalz,et al. Biocompatibility of Dental Materials , 2008 .
[9] W. Valentine,et al. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.
[10] C. Vrints,et al. Bone matrix vesicle-bound alkaline phosphatase for the assessment of peripheral blood admixture to human bone marrow aspirates. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[11] I. Fridovich,et al. Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. , 1987, Analytical biochemistry.
[12] J. Fox,et al. A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. , 1990, Chemical & pharmaceutical bulletin.
[13] Q. Gao,et al. Preparation and in vitro characterization of electrospun PVA scaffolds coated with bioactive glass for bone regeneration. , 2012, Journal of biomedical materials research. Part A.
[14] N. Charoenphandhu,et al. Mechanical properties, biological activity and protein controlled release by poly(vinyl alcohol)-bioglass/chitosan-collagen composite scaffolds: a bone tissue engineering applications. , 2014, Materials science & engineering. C, Materials for biological applications.
[15] P. Luo,et al. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique , 2008, AAPS PharmSciTech.
[16] A. Dash,et al. Therapeutic applications of implantable drug delivery systems. , 1998, Journal of pharmacological and toxicological methods.
[17] J. Fox,et al. Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system for antibiotics. , 1992, Journal of pharmaceutical sciences.
[18] H. A. Mohamed. Effect of Ciprofloxacin on the Articular Cartilage and Epiphyseal Growth Plate Cartilage in the Growing Albino Rats and the Possible Protective Role of Vitamin E (α -Tocopherol): A Histological and Morphometric Study , 2010 .
[19] J. Stepan,et al. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. , 1987, Bone.
[20] S. Rawi,et al. Effect of ciprofloxacin and levofloxacin on some oxidative stress parameters in brain regions of male albino rats , 2011 .
[21] Fan Yang,et al. The future of biologic coatings for orthopaedic implants. , 2013, Biomaterials.
[22] C. Évora,et al. Two-month ciprofloxacin implants for multibacterial bone infections. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] Larry L. Hench,et al. The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.
[24] Hassane Oudadesse,et al. Antioxidative/oxidative effects of strontium-doped bioactive glass as bone graft. In vivo assays in ovariectomised rats , 2012 .
[25] H. Oudadesse,et al. In vitro bioactivity of melt-derived glass 46S6 doped with magnesium. , 2009, Journal of biomedical materials research. Part A.
[26] Julian R Jones,et al. Review of bioactive glass: from Hench to hybrids. , 2013, Acta biomaterialia.
[27] F. Behar-Cohen,et al. Dispositifs de délivrance de principes actifs pour des applications ophtalmologiques , 2007 .
[28] Joseph C Wenke,et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[29] Julie E. Gough,et al. Tissue Engineering Using Ceramics and Polymers , 2007 .
[30] A. Favier,et al. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E , 2002, Human & experimental toxicology.
[31] R. Appleyard,et al. Effects of bioactive glass nanoparticles on the mechanical and biological behavior of composite coated scaffolds. , 2011, Acta biomaterialia.
[32] M. Egerbacher,et al. Confocal laser scanning microscopy of chondrocytes in vitro: cytoskeletal changes after quinolone treatment. , 1998, Scanning.
[33] H. H. Draper,et al. Malondialdehyde determination as index of lipid peroxidation. , 1990, Methods in enzymology.
[34] T. Dutta,et al. Ciprofloxacin-induced bone marrow depression , 1999, Postgraduate medical journal.
[35] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[36] K. Borner,et al. [Concentration of ciprofloxacin in bone tissue]. , 1993, Aktuelle Traumatologie.
[37] Robin Patel,et al. Levofloxacin and Trovafloxacin Inhibition of Experimental Fracture-Healing , 2003, Clinical orthopaedics and related research.
[38] A. Boccaccini,et al. Multifunctional scaffolds for bone tissue engineering and in situ drug delivery , 2014 .
[39] L. Hench,et al. Chemical and mechanical behavior of bioglass-coated alumina. , 1976, Journal of biomedical materials research.
[40] A Delgado,et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[41] J. Huang,et al. 1 – Ceramic biomaterials , 2007 .
[42] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.
[43] M. Mabrouk,et al. Effect of ciprofloxacin incorporation in PVA and PVA bioactive glass composite scaffolds , 2014 .
[44] İ. Tuncay,et al. A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats). , 2005, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES.
[45] T. Minami,et al. The comparative arthropathy of fluoroquinolones in dogs , 1999, Human & experimental toxicology.
[46] M. Mabrouk,et al. Fabrication, Characterization and Drug Release of Ciprofloxacin Loaded Porous Polyvinyl Alcohol/Bioactive Glass Scaffold for Controlled DrugDelivery , 2013 .
[47] W. Li,et al. Preparation and characterization of PHBV microsphere/45S5 bioactive glass composite scaffolds with vancomycin releasing function. , 2014, Materials science & engineering. C, Materials for biological applications.
[48] T. Rebai,et al. Walker 256/B malignant breast cancer cells disrupt osteoclast cytomorphometry and activity in rats: modulation by α-tocopherol acetate. , 2014, Pathology, research and practice.
[49] V. Talla,et al. Oxidative Stress Induced by Fluoroquinolones on Treatment for Complicated Urinary Tract Infections in Indian Patients , 2011, Journal of young pharmacists : JYP.
[50] R. Gurny,et al. [Drug delivery systems for intraocular applications]. , 2007, Journal francais d'ophtalmologie.